All In MedTech

Device Trial Radar · NCT01809665

ProMRI PROVEN Master Study

Master Study for the MRI Compatibility of the Solia S and Solia T Pacing Lead, the Linoxsmart ProMRI and Linoxsmart ProMRI DF4 ICD (Implantable Cardioverter-defibrillator) Lead and the Corox ProMRI OTW Coronary Sinus Lead in Combination With the Ilesto/Iforia ICD or the Evia/Entovis Triple Chamber Pacemaker

Last checked: Nov 20, 2026Latest source record: Mar 2, 2016 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

174

Actual

Start

Jun 2013

Primary completion

May 2015

Study completion Sep 2015

Sponsor

Lead sponsor
Biotronik SE & Co. KGNot on our public-company list
Sponsor type
Industry
First posted
Mar 13, 2013

More device trials from this sponsor

Design

Study type
Observational
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This investigation is designed to provide supporting evidence for the clinical safety of the Ilesto/Iforia ICD (implantable cardioverter-defibrillator)system and the Evia/Entovis HF-T (Heart Failure) triple chamber pacemaker system when used under specific MRI (magnetic resonance imaging) conditions.

Conditions

  • Safety of MR (Magnetic Resonance) Conditional CRT-pacemakers and ICDs

Interventions

  • ICD/CRT-P therapyDevice

  • MRIOther

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The Serious Adverse Device Effect (SADE) -free rate of the ICD/CRT-P system related to MRITime frame: pre-MRI: approx. 2 to 5 months after implantation; post-MRI: 1 month (-2/+4 weeks) after MRI
  2. Increase in atrial and ventricular pacing threshold(s) between pre-MRI and 1-month post-MRITime frame: pre-MRI: approx. 2 to 5 months after implantation; post-MRI: 1 month (-2/+4 weeks) after MRI
  3. Decrease in P-wave and R-wave amplitude (right and left) between pre-MRI and 1-month post-MRI.Time frame: pre-MRI: approx. 2 to 5 months after implantation; post-MRI: 1 month (-2/+4 weeks) after MRI

Locations

23 sites in 8 countries. Site status is shown where the registry gives one.

  • Royal Adelaide Hospital

    Adelaide, Australia

  • Royal Perth Hospital

    Perth, Australia

  • Royal North Shore Hospital

    Sydney, Australia

20 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.